Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
106
HSA:106
Drug Approvals
INVEGA HAFYERA PROLONGED RELEASE SUSPENSION FOR IM INJECTION IN PREFILLED SYRINGE 700MG/3.5ML
- Approval Date
- Dec 19, 2022
HSA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Completed
- Conditions
- High Risk Localized Prostate Cancer
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2024-08-05
- Target Recruit Count
- 221
- Registration Number
- NCT05303558
- Locations
- 🇯🇵
Akita University Hospital, Akita, Japan
🇯🇵Hirosaki University Hospital, Hirosaki, Japan
🇯🇵Nagoya City University Hospital, Nagoya-shi, Japan
News
No news found